Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples